HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Granular cell tumor: an immunohistochemical study.

AbstractAIMS AND BACKGROUND:
Granular cell tumor, usually a benign neoplasm, has been the object of many studies because of its uncertain histogenesis and based on many immunohistochemical and ultrastructural studies it has been suggested that it originates from the Schwann cell. Our recent observation that granular cell tumor is positive with PG-M1, a new anti-macrophage monoclonal antibody, led us to further investigate the immunophenotypic profile of the tumor.
STUDY DESIGN:
We studied 11 granular cell tumors using a panel of 20 antibodies, 13 monoclonal and 7 polyclonal.
RESULTS:
The immunohistochemical study showed in all cases a constant diffuse positivity for S-100 protein, neuron-specific enolase, vimentin, KP1 and PG-M1, as well as occasional and focal positivity for alpha-1-antitrypsin, alpha-1-antichymotrypsin and lysozyme.
CONCLUSIONS:
The immunophenotypic profile constantly observed could be the expression, on one hand, of the neuroectodermic nature of the neoplasm, proven by positivity for S-100 protein, neuron specific enolase and vimentin, and on the other could be the expression of the phagocytic activity of the tumor cell, proven by positivity for KP1 and PG-M1 antibodies and also by the presence of numerous phagolysosomes.
AuthorsA Cavaliere, A Sidoni, I Ferri, B Falini
JournalTumori (Tumori) Vol. 80 Issue 3 Pg. 224-8 (Jun 30 1994) ISSN: 0300-8916 [Print] ITALY
PMID8053081 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Monoclonal
Topics
  • Adult
  • Animals
  • Antibodies, Monoclonal (immunology)
  • Child
  • Female
  • Granular Cell Tumor (chemistry, pathology)
  • Humans
  • Immunohistochemistry
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: